The Scientific Team at AOA Dx Inc. specializes in early-stage cancer detection through cutting-edge biotechnological methods. The Mass Spectrometry Scientist analyzes molecular profiles, the Developmental Therapeutics Head oversees the creation of novel therapeutic strategies, and the Immunoassay Scientist develops and optimizes assays to detect cancer biomarkers efficiently and accurately. Together, they drive the innovation critical for pioneering early cancer detection technologies.
View all